| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.75B | $2.85B | $2.85B |
| YoY Revenue Growth % | +31.5% | -0.2% | — |
| Gross Profit | $454.1M | $339.5M | — |
| Gross Margin % | 12.1% | 11.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $264.8M | $189.9M | $190.5M |
| Operating Margin % | 7.1% | 6.7% | 6.7% |
| Net Income (GAAP) | $201.8M | $143.4M | $137.2M |
| EBITDA (Normalized) | $399.6M | $292.5M | $293.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $156.8M | $163.4M | $171.3M |
| Capital Expenditures (CapEx) | $168.6M | $128.2M | $128.4M |
| Free Cash Flow (FCF) | -$11.7M | $35.1M | $42.9M |
| FCF Margin % | -0.3% | 1.2% | 1.5% |
| Return on Invested Capital (ROIC %) | 29.6% | 26.7% | 7.3% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $266.5M | $280.6M | $801.5M |
| Total Stockholders' Equity | $629.8M | $422.6M | $1.64B |